None listed
Conditions
Interventions
Fentanyl MDTS and Naltrexone for up to 21 days.
Sponsors
Acrux DDS Pty Ltd
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
Male
Age
0 to No maximum
Healthy volunteers
Yes
Inclusion criteria
Healthy volunteers
Exclusion criteria
No exclusion criteria
Outcome results
None listed